Member Info for Elsol

OK AJP & Smart- you have my utmost attention on this one. Basically an innovative dish tab formula (partnered?) with another small UK bio-sustainable venture wishing to phase out petrochemicals use! So we have the core IP and ingredients between ITX and Holiferm (Wirral) - all the other ingredients appear to be very cheap bulk stock generic ingredients. Could provide an amazingly good compelling proposition with reduced pod size/weight/bio and we appear to own the key ingredients and IP! Brilliant . Could ITX & Holiferm partner together on this nice disruptive opportunity? We may have more pricing flexibility and profit on this route also. Keen for company update on this.....

Agreed. I have sent an email to the Company to further advise on this new technology formulation and whether this should be announced formally. I guess for now it's a buying in opportunity.

The reason why I said this is that ITX incremental or synergistic additives can often tip the scales for purchasing decisions and buyer sourcing behaviours and sometimes this is disproportionate to the advancement made in isolation. But in the complete product offer perspective it makes a standout market proposition that is market disruptive.

I suspect an RNS will come out on the day of the Florida congress event when the detailed technology reveal occurs . I did flag to the company some of the new product launch intel. is already in the public domain re: AJP's findings from the Congress advance agenda. ITX can disclose the RNS when they deem necessary which I believe will be aligned to the 90 minute presentation by John that will be in full 3D. 😉 I do think this launch is material to investors and ITX performance Outlook.

Great investigative sleuthing AJP. Gold star! Looks a new compelling ITX proposition for upcoming pivotal US cleaning congress. The ITX tail may be wagging the large dog product US brands v. soon not the other way around!

They probably needed the cash short term to pay staff wages and/or overhead or commissions in the VCT. If they had a 6-8 month investment horizon, I'm sure they wouldn't have sold shares below 120p because it has the potential to go alot higher with the full YE results announcement and inbound sales traction/ newsflows (near term). SmartInvestor and the ITX senior exec insider can't both be wrong 😉 on SP trajectory!

18. A Share price that looks very over sold and under a bushel until new investors see the growth opportunity from less than £20m mkt cap .

A very interesting Q1/Q2 outlook unfolding here for new and existing investors is my take...

So everyone where does the ITX story go next? - A brief recap on where we are as @ Jan 26:

1. Business appears to be booming on the back of long awaited sustainable ITX chemistries driving market traction in new and existing brands and SPARX / partnering initiatives.

2. Promise of new lumpy large account switching to ITX formulations, given successful differentiation of smaller and mid-size brands, taking market share from the majors.

3. A less than happy " historical" shareholder base that wanted more jam, quicker than was actually delivered and in the backdrop of a large peak in share price that may be unwarranted at the time ( shareholders locked from higher price). Shareholder apathy from 2021 base camp.

4. A rubbish web site that was excellently converted to a global, first class brand focused marketing outreach engine.

5. A somewhat arguable shr consolidation that made the share price feel expensive when actually the market cap is still peanuts in comparison to growth on the horizon and valuation fundamentals.

6. A past large finance raise of $10m at c. 255p leaving professional investors underwater- awaiting a well overdue rebound to align to the original professional investor case given major risk being unwound on ITX business investment case.

7. A transition to EBITDA breakeven in H2 within 6 months, then powering forwards given strong revenue trajectory. Additional silent messaging from CEO on 2026 outperformance given another expected record year ahead.

8. A broker unchanged at 325p aligned with industry multiples for larger companies that may want to acquire our golden tickets at any point going forwards.

9. An aging CEO that presumably is eager for more outperforming growth and business success and a multibag exit sooner rather than later to enjoy his retirement.

10. A business growing international supply options in diverse sticky brand centric customer markets with low switching risk.

11. A market that is still ripe for sustainable chemistry applications and major growth to at least 2030.

12. The 'Trump' uncertainty factor related to Chinese feedstock supply, offset by latent efforts to diversify supply chains from likes of India and South America.

13. Cash in the bank through to profitability but with the prospect for upside investment options for growth ( equity and debt financing to reduce cost of capital of the business - WACC).

14. Another plant facility envisioned to spread geographic production footprint and to add scale and geographic cost efficiencies.

15. Prospect for more progressive application-led patents to add critical mass to existing IP portfolio.

16. Recent Director buy informing investment mindset of close company insiders .

17. An optical share price today that is the effectively the same as when the company had much less positive features and characteristics including much less delivery risk than back in 2020.

AJP, apologies, what's the relevance of cosmileurope??

Good spot AJP! Looks promising for ITX to upsell into GOJO channels.

I do sense John has some larger account or product brand conversions in play at the moment that are as good as nailed on. I can't figure any other reason for such a bullish CEO statement a few days ago that ITX "will have another record breaking year this year (2026)". Plus we have a decent Director buy to back that up - we haven't had knowledgeable insiders buying for a few years. I guess its saying that the strategic pivot and transformation to higher GMs and wider SPARX and web site traction are paying off.

LOL keep buying Smart, you are driving the price up and bringing new investors with you! 🤣 . I don't doubt 2026 is the year of SP growth we all long deserve as ITX transitions through cashflow breakeven and upward. Its a no brainer really, good GMs and more revenues inbound will reignite investor interest and confidence in a well undervalued MAGA business sitting under the radar.

MMs collecting a few today on stop losses and from S/T trader positions but all is very strong under the ITX bonnet and soon the full detailed results from Fy25 will be V. interesting with all our Qs on pipeline and CEO comments.

Amazingly , John has already said on camera with Proactive that 2026 WILL BE another record breaking year for ITX in revenue terms. Given we are only in mid Jan 26 that's a massively bullish statement that must be backed up by large upsides over the comparable FY 25 performance. This could be from confidence that large switching of volumes is almost a given is my guess during H1 2026. I can't understand any other reason why a CEO would or could announce this on record without a very large probability that the company would deliver on that promise. Hence I understand Smart putting more investment in. I'm already fully in otherwise I would follow like the ITX Director already investing.

Agree this Director buy coupled with John's very positive latent messaging in recent days to shareholders speaks volumes. ITX is an extremely strong buy now for me and I've never expressed that before peeps.

We know there are some larger players interested in ITX ingredient supply as per company confirmation (in funnel). Once one or two of these are landed the SP will react/re-rate upward I'm sure of that. It's just a matter of waiting as SI mentioned. However, the overall sentiment coming from the company at the moment appears to be super bullish for more of the same in 2026 (strong growth and good inbound pipeline).

Hi Marcus, this may help you stay aligned for possible large upside - see below my email to John and Laura followed by a interesting, candid response from John. You can read into this as you want, but looks really good from where I'm sitting on a decent stockpile of shares - keep the faith, its coming home...

"Dear John and Laura,

A belated Happy New Year!

Congratulations to you both and the entire ITX team for delivering a fantastic FY25 performance as a result of significant efforts during 2024 and 2025.

Well done everyone.

Best regards,"

"Hi ******

Thank you for your note.

Truly a milestone year. Feels great - and more to come.

Regards,

John

The present investment case (TODAY) for new investors to onboard is very strong given ITX tiny price point and market cap v's its performance and execution risk position. There is still execution risk as for any business but that risk is reducing with each day given market adoption and traction. One could argue that invesment risk has been majorly reduced given rev. perfromance, client success and upside pipeline today compared to, say, 3 or 4 years ago. Bigger acquisitive companies will be aware of ITX very high growth and stellar performance especially if ITX are switching clients off their portfolios. I've said this before but nobody wanted to listen and I will not say it again.. Latent large frustrations voiced on boards like this (some that are now largely historic / irrelevant to new investors) can impact new shareholder investing in any stock. Please reflect whether shareholders are creating a self fulfilling prophecy and bad atmosphere that creates a temporary barrier to share price growth! This then means obvserved SP lags the true intrinsic value of the company. Have a think on this everyone. Every company is imperfect , it is what makes them unique and special but for now the future and new shareholder case looks very bright so let's not interfere in that shareholder upside journey.

I really think 2026 is a highly exciting transition year for ITX; EBITDA cashflow breakeven H2, more manufacturing scale, possibility of larger client contracts switching to ITX (scale inhibition as example), more global acct. diversification, more emerging applications, new patents, more traction/mkt share with existing loyal brands, more staff in the company to extend teaming bandwidth, more impact in sustainable markets, more BD is inbound AND more KPI reporting via RNS. Wake up everyone, loose the glass half full mentality. John sent an email personally to me as a message to all shareholders, it kind of said "watch this space because its looking the best it has ever been for all shareholders right now" and we have just breached $10m in sales due to a massive amount of dedication and professional focus of the ITX team during both 2024 and 2025 to realise the full potential of the company.

PE based multiples are less relevant for high growth IP fuelled businesses that are in the "high growth" phase ( for us that's at least to 2030 ). Once ITX become more mature and comparable to other mature businesses its more indicative and relevant. Cashflow based DCF valuation approach is best valuation method for ITX IMHO.